Please use this identifier to cite or link to this item:
https://dora.health.qld.gov.au/qldresearchjspui/handle/1/4772
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Clark, J. E. | en |
dc.contributor.author | Ullman, Amanda | en |
dc.contributor.author | Kleidon, T | en |
dc.contributor.author | Graham, N. | en |
dc.date.accessioned | 2022-11-07T23:56:12Z | - |
dc.date.available | 2022-11-07T23:56:12Z | - |
dc.date.issued | 2019 | en |
dc.identifier.citation | Jan 38, (1), 2019, p. e16-e18 | en |
dc.identifier.other | RIS | en |
dc.identifier.uri | http://dora.health.qld.gov.au/qldresearchjspui/handle/1/4772 | - |
dc.description.abstract | This study describes a successful, targeted intervention in central venous access device routine care to decrease central line-associated bloodstream infection. Taurolidine-citrate locks significantly reduced the rate of central line-associated bloodstream infection, particularly Gram-negative organisms without adverse events.1532-0987Clark, Julia E <br />Graham, Nicolette <br />Kleidon, Tricia <br />Ullman, Amanda <br />Journal Article <br />United States <br />Pediatr Infect Dis J. 2019 Jan;38(1):e16-e18. doi: 10.1097/INF.0000000000002191. <br /> | en |
dc.language.iso | en | en |
dc.relation.ispartof | Pediatr Infect Dis J | en |
dc.title | Taurolidine-Citrate Line Locks Prevent Recurrent Central Line-Associated Bloodstream Infection in Pediatric Patients | en |
dc.type | Article | en |
dc.identifier.doi | 10.1097/inf.0000000000002191 | en |
dc.subject.keywords | Central Venous Catheters/*adverse effects | en |
dc.subject.keywords | Child | en |
dc.subject.keywords | Child, Preschool | en |
dc.subject.keywords | Citric Acid/pharmacology | en |
dc.subject.keywords | Cross Infection/microbiology/prevention & control | en |
dc.subject.keywords | Female | en |
dc.subject.keywords | Gram-Negative Bacteria/drug effects | en |
dc.subject.keywords | Bacteremia/*prevention & control | en |
dc.subject.keywords | Infant | en |
dc.subject.keywords | Male | en |
dc.subject.keywords | Taurine/*analogs & derivatives/pharmacology | en |
dc.subject.keywords | Thiadiazines/*pharmacology | en |
dc.subject.keywords | AdolescentAnti-Infective Agents, Local/*pharmacology | en |
dc.subject.keywords | Humans | en |
dc.subject.keywords | Catheter-Related Infections/microbiology/*prevention & control | en |
dc.subject.keywords | Catheterization, Central Venous/adverse effects/instrumentation | en |
dc.subject.keywords | Catheters, Indwelling/*adverse effects | en |
dc.identifier.risid | 3312 | en |
dc.description.pages | e16-e18 | en |
local.message.claim | 2024-06-20T09:40:17.715+1000|||rp03979|||submit_approve|||dc_contributor_author|||None | * |
item.cerifentitytype | Publications | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.languageiso639-1 | en | - |
item.openairetype | Article | - |
item.grantfulltext | none | - |
item.fulltext | No Fulltext | - |
Appears in Sites: | Children's Health Queensland Publications Queensland Health Publications |
Items in DORA are protected by copyright, with all rights reserved, unless otherwise indicated.